Chlamydia pneumoniae seropositivity and risk of ischemic stroke: A nested case-control study

European Journal of Epidemiology

Volumn 20, Issue 1, 2005, Pages 59-65

  Johnsen, Søren P ^a   Overvad, Kim ^b   Østergaard, Lars ^c   Tjønneland, Anne ^d   Husted, Steen E ^c   Sørensen, Henrik T ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Cerebrovascular disorders; Chlamydia pneumoniae; Epidemiology; Infection; Risk factors

Indexed keywords

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA PNEUMONIAE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION RISK; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RISK ASSESSMENT; RISK FACTOR; SEROTYPING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TITRIMETRY;

AGED; ANTIBODIES, BACTERIAL; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHLAMYDOPHILA PNEUMONIAE; DENMARK; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 13444257592     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10654-004-4341-5     Document Type: Article

References (34)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430-436.
3. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin Microbiol Infect 2002; 8: 2-13.
4. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis. Br Med J 2000; 321: 208-213.
5. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebro-vascular disease. Stroke 1996; 27: 2207-2210.
6. Cook PJ, Honeybourne D, Lip GYH, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. Stroke 1998; 29: 404-410.
7. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease. Stroke 1999; 30: 299-305.
8. Elkind MSV, Lin I-F, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke. Stroke 2000; 31: 1521-1525.
9. Wolf SC, Mayer O, Jurgens S, et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003; 59: 273-279.
10. Madre JG, Garcia JL, Gonzalez RC, et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002; 9: 303-306.
11. Glader CA, Stegmayr B, Boman J, et al. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Stroke 1999; 30: 2013-2018.
12. Heuschmann PU, Neureiter D, Gesslein M, et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes. Stroke 2001; 32: 2253-2258.
13. Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS)): A case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 2003; 15: 11-16.
14. Melnick SL, Shahar E, Folsom AR, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993; 95: 499-504.
15. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-3400.
16. Schmidt C, Hulthe J, Wikstrand J, et al. Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness. Stroke 2000; 31: 1526-1531.
17. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan Acute Respiratory) seropositivity. Circulation 2001; 103: 1390-1395.
18. LaBiche R, Koziol D, Quinn TC, et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32: 855-860.
19. Virok D, Kis Z, Karai L, et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 2001; 32: 1973-1978.
20. Prager M, Turel Z, Speidl WS, et al. Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2002; 33: 2756-2761.
21. Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 1999; 100: 832-837.
22. Coles KA, Plant AJ, Riley TV, Smith DW, McQuillan BM, Thompson PL. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. Am J Cardiol 1999; 84: 825-828.
23. Tjønneland A, Overvad K. Diet, cancer and health - a prospective cohort study and biological bank in Denmark (In Danish). Ugeskr Laeger 2000; 162: 350-354.
24. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. Dan Med Bull 1999; 46: 263-268.
25. Johnsen SP, Overvad K, Sorensen HT, Tjonneland A, Husted SE. Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients. J Clin Epidemiol 2002; 55: 602-607.
26. National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases. III. Stroke 1990; 21: 637-676.
27. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41.
28. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies, I: Principles. Am J Epidemiol 1992; 135: 1019-1028.
29. Persson K, Boman J. Comparison of five serologic tests for diagnosis of acute infections by C. pneumoniae. Clin Diagn Lab Immunol 2000; 7: 739-744.
30. Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150: 149-156.
31. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: Critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002; 15: 1-20.
32. Epstein SE, Zhu J. Lack of association of infectious agents with risk of future myocardial infarction and stroke. Definitive evidence disproving the infection/ coronary artery disease hypothesis? Circulation 1999; 100: 1366-1368.
33. Siscovick DS, Schwartz SM, Caps M, Wang SP, Grayston JT. Chlamydia pneumoniae and atherosclerotic risk in populations: The role of seroepidemiology. J Infect Dis. 2000; 181(Suppl 3): S417-S420.
34. Paganini-Hill A, Lozano E, Fischberg G, et al. Infection and risk of ischemic stroke. Stroke 2003; 34: 452-457.